M Mai
Impact in
- Oncology top 5%
- Colorectal Cancer Screening and Detection
- Colorectal Cancer Treatments and Studies
- Cancer-related Molecular Pathways
- Peptidase Inhibition and Analysis
- HER2/EGFR in Cancer Research
- Cancer Research top 10%
Papers in
- Oncology 12
- Colorectal Cancer Treatments and Studies 3
- HER2/EGFR in Cancer Research 2
-
- Glycosylation and Glycoproteins Research 2
- Co-authors
- Toshinari Minamoto (5 shared papers)Aikseng Ooi (4 shared papers)Ze’ev A. Ronai (1 shared paper)K Sawaguchi (4 shared papers)Isao Nakanishi (2 shared papers)Kazuyoshi Yanagihara (1 shared paper)Masaaki Kobayashi (1 shared paper)Takuo Hara (1 shared paper)
- Journals
- JNCI Journal of the National Cancer Institute (1 paper)The Journal of Immunology (1 paper)Naunyn-Schmiedeberg s Archives of Pharmacology (1 paper)Endoscopy (1 paper)Journal of Molecular Biomarkers & Diagnosis (1 paper)
- Partner nations
- JapanGermanyUnited States
In The Last Decade
M Mai
22 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 68
- Oncology 592
- Cancer Research 220
- Pathology and Forensic Medicine 250
- Hepatology 61
- Pulmonary and Respiratory Medicine 239
Countries citing papers authored by M Mai
This map shows the geographic impact of M Mai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Mai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Mai more than expected).
Fields of papers citing papers by M Mai
This network shows the impact of papers produced by M Mai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Mai. The network helps show where M Mai may publish in the future.
Co-authors
The 25 scholars most cited alongside M Mai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Amplification of c-myc, K-sam, and c-met in gastric cancers: detection by fluorescence in situ hybridization. | 1998 | 153 |
| 2 | 2004 | 146 | |
| 3 | Infrequent K-ras activation in superficial-type (flat) colorectal adenomas and adenocarcinomas. | 1994 | 113 |
| 4 | K-ras mutation: early detection in molecular diagnosis and risk assessment of colorectal, pancreas, and lung cancers--a review. | 2000 | 110 |
| 5 | 1997 | 98 | |
| 6 | Early invasive colorectal carcinomas metastatic to the lymph node with attention to their nonpolypoid development. | 1993 | 93 |
| 7 | Tissue inhibitor of metalloproteinase 1 is a negative regulator of the metastatic ability of a human gastric cancer cell line, KKLS, in the chick embryo. | 1993 | 93 |
| 8 | Amplification of the c-erbB-2 (HER-2/neu) gene in gastric cancer cells. Detection by fluorescence in situ hybridization. | 1997 | 89 |
| 9 | Molecular analysis of the cytokine network involved in cachexia in colon 26 adenocarcinoma-bearing mice. | 1995 | 78 |
| 10 | Amplification of c-erbB-2 in gastric cancer: detection in formalin-fixed, paraffin-embedded tissue by fluorescence in situ hybridization. | 1998 | 42 |
| 11 | Analysis of chromosome 17p13 (p53 locus) alterations in gastric carcinoma cells by dual-color fluorescence in situ hybridization. | 1996 | 38 |
| 12 | 1987 | 31 | |
| 13 | [Clinicopathological study of AFP producing gastric cancer--significance of AFP in gastric cancer]. | 1987 | 28 |
| 14 | β-catenin and ras oncogenes detect most human colorectal cancer | 2006 | 4 |
| 15 | 1985 | 2 | |
| 16 | [Clinicopathological study of minute stomach cancer]. | 1986 | 2 |
| 17 | [Significance of prolonged NC as an endpoint of chemotherapy for solid tumors]. | 2000 | 2 |
| 18 | Oncogenic β-catenin and MMP-7 cosegregate in late-stage clinical colon cancer | 2003 | 1 |
| 19 | [Determination of serum DU-PAN-2 by enzyme immunoassay in patients with various digestive cancers]. | 1987 | 1 |
| 20 | 2015 | 1 |
About M Mai
M Mai is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Cancer Research, having authored 22 papers that have together received 1.1k indexed citations. Recurring topics across this work include Genetic factors in colorectal cancer (5 papers), Lung Cancer Treatments and Mutations (4 papers), Colorectal Cancer Treatments and Studies (3 papers), Metastasis and carcinoma case studies (3 papers), Gastric Cancer Management and Outcomes (3 papers), HER2/EGFR in Cancer Research (2 papers), Glycosylation and Glycoproteins Research (2 papers) and Colorectal and Anal Carcinomas (2 papers). The work is most often cited by research in Oncology (592 citations), Cancer Research (220 citations), Pathology and Forensic Medicine (250 citations), Hepatology (61 citations) and Pulmonary and Respiratory Medicine (239 citations). M Mai has collaborated with scholars based in Japan, Germany and United States. Frequent co-authors include Toshinari Minamoto, Aikseng Ooi, Ze’ev A. Ronai, K Sawaguchi, Isao Nakanishi, Kazuyoshi Yanagihara, Masaaki Kobayashi, Takuo Hara, Serge Y. Fuchs and Vladimir Bilim. Their work appears in journals such as JNCI Journal of the National Cancer Institute, The Journal of Immunology, Naunyn-Schmiedeberg s Archives of Pharmacology, Endoscopy and Journal of Molecular Biomarkers & Diagnosis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.